Next Article in Journal
Maternal Methyl Donors Supplementation during Lactation Prevents the Hyperhomocysteinemia Induced by a High-Fat-Sucrose Intake by Dams
Next Article in Special Issue
Clinical Evaluation of Extracellular ADMA Concentrations in Human Blood and Adipose Tissue
Previous Article in Journal
Cbl-b Enhances Sensitivity to 5-Fluorouracil via EGFR- and Mitochondria-Mediated Pathways in Gastric Cancer Cells
Previous Article in Special Issue
Opposite Associations of Plasma Homoarginine and Ornithine with Arginine in Healthy Children and Adolescents
Open AccessEditorial

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease

Department of Medicine and Science of Aging, University G. D'Annunzio-Chieti, Chieti 66100, Italy
Intensive Cardiology Care Unit, San Camillo de Lellis Hospital, San Severo (FG) 71016, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(12), 24412-24421;
Received: 29 October 2013 / Revised: 5 December 2013 / Accepted: 6 December 2013 / Published: 16 December 2013
(This article belongs to the Special Issue ADMA and Nitrergic System)
Note: In lieu of an abstract, this is an excerpt from the first page.

There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) may contribute to endothelial dysfunction. Studies in animal models as well as in humans have suggested that the increase in ADMA occurs at a time when vascular disease has not yet become clinically evident. ADMA competitively inhibits NO elaboration by displacing L-arginine from NO synthase. In a concentration-dependent manner, it thereby interferes not only with endothelium-dependent, NO-mediated vasodilation, but also with other biological functions exerted by NO. The upshot may be a pro-atherogenic state. Recently, several studies have investigated the effect of various therapeutical interventions on ADMA plasma concentrations. [...] View Full-Text
Keywords: ADMA; nitric oxide; cardiovascular disease ADMA; nitric oxide; cardiovascular disease
MDPI and ACS Style

Franceschelli, S.; Ferrone, A.; Pesce, M.; Riccioni, G.; Speranza, L. Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease. Int. J. Mol. Sci. 2013, 14, 24412-24421.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop